Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Homophilic interaction of the L1 family of cell adhesion molecules.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Cognitive Impairment Has a Strong Relation to Nonsomatic Symptoms of Depression in Relapsing-Remitting Multiple Sclerosis.
Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells.
Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
The potential for new therapeutic approaches: Global research collaboration examines multiple pathways of neuroprotection in Huntington disease
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis.
Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?
Newly diagnosed multiple sclerosis in state of Qatar.
DMDs Are an Essential Issue But Are They the Only Issue in MS Treatment?
[Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal.]
Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden.
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Simvastatin in acute optic neuritis.
A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register.
Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation.
Toll-like receptors in central nervous system injury and disease: A focus on the spinal cord.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
Personalized Medicine in Neurodegenerative Diseases: How Far Away?
DemTect, PANDA, EASY, and MUSIC: Cognitive Screening Tools with Age Correction and Weighting of Subtests According to Their Sensitivity and Specificity.
Pages
« first
‹ previous
…
181
182
183
184
185
186
187
188
189
…
next ›
last »